Introduction
============

Osteoporosis is a metabolic bone disease characterized by increased bone fragility due to decreased bone mass and altered bone microstructure, and is associated with high mortality, morbidity, and treatment costs.[@b1-cia-9-1375] The World Health Organization reported that 35% of the women in the US older than 65 years had osteoporosis in 1994.[@b2-cia-9-1375] The most dreaded complication of osteoporosis is bone fracture, particularly of the hip. In 1990, 1.3 million hip fractures were reported worldwide, and this figure is expected to double by 2025 and to reach 4.5 million by 2050.[@b3-cia-9-1375] The relationship between trace elements and the etiology of osteoporosis is intriguing. The role of alterations in such trace elements as magnesium, copper, zinc, manganese, cadmium, and lead in the development of osteoporosis and the effects of treating mineral profiles on osteoporosis have yet to be fully elucidated.

Magnesium, a ubiquitous element in various organ systems, is thought to play a role in the mineral metabolism of both soft and hard tissues. It mimics the actions of Ca in transport and mineralization processes, and is required for normal Ca absorption. Its roles in bone metabolism and in the development of metabolic bone disease are not fully understood. Furthermore, whether Mg deficiency results in osteoporosis is unknown, with conflicting reports on the Mg content of osteoporotic bone.[@b4-cia-9-1375]

Zinc is a component of the cell nucleus, mitochondria, cytoplasm, and plasma membrane, and is involved in the synthesis of several metalloenzymes.[@b5-cia-9-1375]--[@b7-cia-9-1375] It is an essential component of enzymes involved in transcription, translation, and nucleic acid synthesis, which have important roles in the metabolic activity of bone.[@b5-cia-9-1375] In addition, bone zinc content is decreased postmenopausally, and with aging and skeletal unloading, suggesting a role in bone disorders.[@b8-cia-9-1375]

Therefore, this study compared the trace-element concentrations in bone and the radiographic bone density and bone mineral density (BMD) of two groups of patients: those undergoing partial hip prosthesis due to an osteoporotic proximal femoral fracture, and those undergoing total hip arthroplasty due to osteoarthritis.

Patients and methods
====================

Patients
--------

This study included 30 patients operated on at the Orthopedics and Traumatology Department of Erciyes University Medical School between December 2008 and December 2009 for osteoporotic proximal femur fractures after falls, consisting of nine men 70--85 mean ± SD (72.8±6.08) years old and 21 women 61--92 (73.9±9.7) years old. A further 30 patients undergoing hip arthroplasty in the same center for primary hip osteoarthritis consisted of nine men 60--67 (63.2±6.6) years old and 21 women 50--70 (60.5±5.1) years old. The females in both groups were postmenopausal. A history of high-impact trauma, previous treatment for osteoporosis (bisphosphonates, raloxifene, calcitonin, hormone-replacement therapy, vitamin D and its derivatives, etc), systemic steroid use, malignancy associated with bone metastases, and other secondary causes of osteoporosis comprised the exclusion criteria. The study protocol was approved by the Erciyes University Local Ethics Committee 2008/608, December 2, 2008).

Surgical sampling
-----------------

All patients had prosthetic hip replacements. During the surgical procedure, the soft tissues surrounding the femoral head were displaced, after which the femoral head and neck were extracted from the acetabulum manually in all patients to avoid any metal contamination. Then, the sample was cleaned using 1,000 mL of physiological saline and stored at −70°C for biochemical and radiological examinations.

Assessments
-----------

### Radiological assessment of bone tissue samples

All of the frozen samples from the patient and control groups (ie, the proximal femur bone samples) were examined with 1.25 mm-thick cross sections using a LightSpeed^®^ 16-multislice computed tomography device (GE Healthcare, Waukesha, WI, USA) in a single session. Reformatted images were obtained with an Infinitt (Phillipsburg, NJ, USA) picture-archiving and communication-system viewer. The tomographic densities were calculated using the Hounsfield scale at three different points limited to spongy bone. With this scale, the attenuation factor for the X-rays diffusing through the tissues is calculated numerically to represent each pixel. The numbers are arranged on a scale between +1,000 and −1,000 where the attenuation value of water is zero.

### Biochemical assessment of bone tissue samples

The bone specimens obtained from the patients were transferred to the laboratory and dried in an oven at 110°C until a constant weight was reached. This procedure was used to determine the water content (gravimetric method). Dried samples were ground in an agate mortar. Bone material was mineralized using wet digestion in a Velp Scientifica mineralizer (Usmate Velate, Italy).[@b9-cia-9-1375],[@b10-cia-9-1375] The analytical ash sample (approximately 1 g) was digested in 2 cm^3^ of spectrally pure HNO~3~ (V) (Suprapur^®^; Merck Millipore, Billerica, MA, USA). The bone samples were dissolved in 10 mL of concentrated HNO~3~ using a microwave oven. Then, the samples were diluted to a volume of 25 mL using distilled water for inductively coupled plasma mass spectrometry (ICP-MS).

Determination
-------------

A PerkinElmer (Norwalk, CT, USA) model A Analyst 800 flame atomic absorption spectrometer equipped with a deuterium background-correction system and an air-acetylene burner was used to determine Ca(II) and Mg(II) at wavelengths of 422.7 and 285.2 nm, respectively, using standard working parameters: spectral bandwidth 0.2 nm, acetylene flow rate 1.4 L·min^−1^, and nebulizer flow rate 10 mL·min^−1^.

Then, 100 μL of each the dissolved bone samples was diluted using 10 mL of 1 M HNO~3~ for magnesium determination. To measure calcium, 50 μL of 2% lanthanum solution was added to 50 μL of the dissolved bone sample to eliminate the risk of a faulty measurement, due to the high phosphate content of the bone. Then, the volumes were made up to 10 mL for flame atomic absorption spectrometry.

For ICP-MS, an Agilent 7500A (Agilent Technologies, Santa Clara, CA, USA) was used with a Consort (Turnhout, Belgium) model C533 pH meter combined with a glass electrode. For each dissolved bone sample, a 10 mL sample was obtained and neutralized using 1 M NaOH. Then, the pH was adjusted to 4.5 with a magnetic mixer following an optimized procedure. Next, 1 mL of 1% ammonium pyrrolidine dithiocarbamate (APDC) solution was added to each sample and mixed for 10 minutes. The sample solution was then transferred to a separatory funnel. The metal--APDC chelate was extracted by shaking the mixture for 2 minutes with 5+5 mL of methyl isobutyl ketone. The two phases were allowed to separate, and then the organic phase was transferred to another separatory funnel. To this organic phase, 10 mL of 2 M HNO~3~ was added and mixed thoroughly, and then the metal--APDC chelate was back-extracted from the methyl isobutyl ketone into 2 M HNO~3~. To determine the metal concentrations, the aqueous phase was analyzed using ICP-MS. For each sample, two or three repetitions were performed, and statistical analysis was used to average the data, which were expressed as micrograms per gram dry weight (dw). In order to verify the accuracy of the procedure, the method for certified reference materials was used (CRM-1486).[@b10-cia-9-1375] The results are shown in [Tables 1](#t1-cia-9-1375){ref-type="table"} and [2](#t2-cia-9-1375){ref-type="table"}.

Bone mineral-density measurement
--------------------------------

In both patient groups, BMD, Z-scores, and T-scores were measured in the unaffected hip with dual-energy X-ray absorptiometry (DEXA) using a QDR-4500A (Hologic, Bedford, MA, USA) within the first week after surgery. DEXA was performed with the patient in a supine position, with the hip joint rotated 15° internally. Osteophytes and sclerotic margins were excluded from the measurement.

Statistical analyses
--------------------

SPSS 21.0 (IBM, Armonk, NY, USA) was used for the statistical analyses. Descriptive statistics are presented as means and standard deviation. The homogeneous distribution of the groups was tested using the Kolmogorov--Smirnov and Shapiro--Wilk tests. Variables with normal distributions were evaluated using the independent *t*-test, while those with abnormal distributions were tested using the Mann--Whitney *U* test. The associations among variables were assessed using Spearman's and Pearson's correlation analyses. A *P*-value \<0.05 was considered to indicate statistical significance.

Results
=======

The fracture group was significantly older than the osteoarthritis group (mean age 77.4±8.6 versus 64.6±6.1 years, *P*\<0.001). The groups did not differ with regard to sex distribution (male:female ratio 9:21 in both groups, *P*=1.000). The patients in the fracture group all underwent a partial hip arthroplasty; this was for intertrochanteric fractures in ten patients and for femoral neck fractures in 20 patients. All patients in the osteoarthritis group underwent total hip arthroplasty.

The two groups are compared in [Table 3](#t3-cia-9-1375){ref-type="table"}. Of the biochemical parameters, the tissue levels of magnesium (1.908±507 μg·g^−1^ dw versus 2,540±435 μg·g^−1^ dw, *P*\<0.05), calcium (10.4±3.5 μg·g^−1^ dw versus 13.9±3.7 μg·g^−1^ dw, *P*\<0.05), and zinc (2,342±1,252 μg·g^−1^ dw versus 3,145±1,604 μg·g^−1^ dw, *P*\<0.05) were significantly lower in the fracture group, whereas the groups did not differ with regard to the other biochemical parameters.

All of the DEXA findings were significantly worse in the fracture group compared to the osteoarthritis group (T-score, −3±1.2 versus −1.1±0.8, *P*\<0.05; Z-score, −1.13±1.2 versus 0.05±0.8, *P*\<0.05; and BMD, 0.6±0.1 versus 0.8±0.09, *P*\<0.001); however, the groups did not differ radiologically in femoral neck density assessed using the Hounsfield scale ([Table 4](#t4-cia-9-1375){ref-type="table"}). According to the Spearman analysis, Ca (*r*=0.49), Zn (*r*=0.26), Mg (*r*=0.56), T-scores (*r*=0.74), Z-scores (*r*=0.56), and BMD (*r*=0.67) were negatively correlated with the presence of fracture (*P*\<0.05).

When the two groups were pooled and a correlation analysis was performed, the following parameters were significantly and negatively correlated with age: magnesium, *r*=−0.436, *P*\<0.001; calcium, *r*=−0.331, *P*=0.01; T-score, *r*=−0.381, *P*=0.003; Z-score, *r*=−0.267, *P*=0.044; and BMD, *r*=−0.365, *P*=0.004. Tissue magnesium levels were significantly correlated with T-scores (*r*=0.363, *P*=0.004) and BMD (*r*=0.309, *P*=0.016). Similarly, tissue calcium levels were correlated with T-scores (*r*=0.302, *P*=0.019) and BMD (*r*=0.256, *P*=0.049). Though there was a correlation between T-scores and Zn, it was not significant.

When sex effects were evaluated, Ca, Mg, T-scores, Z-scores, and BMD were significantly lower in the fracture group for females, while Zn levels were included in this list for males. In the fracture group, females had significantly lower Zn levels than males (*t*=−2.146, *P*=0.041); interestingly, Mn levels were significantly higher in females (*U*=43, *P*=0.002).

Although the relationship between Ca/Mg and Zn levels (*r*=0.015, *P*\>0.05) was not significant, there was a strong correlation between Ca/Mg (*r*=0.844) levels in the fracture group and Ca/Zn (*r*=0.32) and Zn/Mg (*r*=0.438) when evaluated in both groups. In the Spearman analysis, despite positive correlations between Fe, K, Cr, Pb, and As levels and the presence of fracture, they were not significant (*P*\>0.05).

Discussion
==========

This study compared the bone mineral concentrations, mineral density, and radiological density in patients with femoral fractures or osteoarthritis. As expected, patients with bone fractures had lower BMD, T-scores, and Z-scores than those with osteoarthritis. Similarly, the calcium concentration in the bones with fractures was lower. In addition, the concentrations of a large number of trace elements were examined, with Ca, Mg, and Zn levels being lower in cases with femoral fractures, as shown by DEXA. However, there were no significant differences in the other trace element levels and tomographic Hounsfield-unit levels. We are convinced that this situation would change using quantitative computed tomography and increasing the number of subjects.

Several clinical studies have reported chronic Mg deficiency in postmenopausal women with osteoporosis.[@b11-cia-9-1375]--[@b16-cia-9-1375] Nielsen found a reduced concentration of ionized calcium due to Mg deficiency, and concluded that Mg is required for optimal Ca metabolism and that elderly males and postmenopausal females need Mg to prevent the severe bone loss that is common in these populations.[@b17-cia-9-1375] Increased numbers of osteoclasts, decreased osteoblastic function, and accelerated bone mineralization have been observed in association with magnesium deficiency, suggesting that altered metabolic turnover and mineralization in bone causes bone fragility.[@b18-cia-9-1375],[@b19-cia-9-1375] In our study, subjects with femoral neck fractures had significantly lower bone Mg concentrations than those with osteoarthritis, and there was a negative correlation between age and Mg content in the overall study group. In addition, there was a positive correlation between Mg levels and BMD. Collectively, these data support the suggestions that low Mg increases the risk of fracture.

Calhoun reported increased zinc uptake during bone healing in rats.[@b20-cia-9-1375] In experimental animal models, Zn deficiency has been associated with altered osteoblastic activity and decreased synthesis of collagen, chondroitin sulfate, and alkaline phosphatase.[@b21-cia-9-1375] Despite conflicting data on the bone zinc concentration in patients with osteoporosis, there is a consensus regarding the important role of Zn in bone metabolism.[@b22-cia-9-1375]--[@b25-cia-9-1375] Steidl and Ditmar reported lower Zn concentrations in patients with senile or postmenopausal osteoporosis, suggesting an association between zinc and magnesium in patients with osteoporosis.[@b26-cia-9-1375] To investigate the role of Zn in osteoporosis, Matarán Pérez et al explored the relationship between the oral intake of Zn through nutrition and urinary and serum levels of Zn, finding no significant difference in serum Zn levels between osteoporotic and nonosteoporotic subjects.[@b27-cia-9-1375] A new finding -- that the zinc status of osteoporotic patients is significantly different from that of patients with osteoarthritis -- supports the view that these two conditions rarely occur in the same individual.[@b28-cia-9-1375] In our study, the Zn content of bone was marginally significantly lower in fracture patients compared to osteoarthritis patients, but there was no correlation between Zn and BMD. Considering the contradictory data, further work is necessary to better define the role of Zn in the development of osteoporosis.

Several studies have looked at the association between trace-element intake and bone parameters, in addition to the possible benefits of supplementation with trace elements. In a study of 159 females, Angus et al found that forearm BMD was positively correlated with Fe, Zn, and Mg intake, and suggested that nutritional factors other than calcium play a role in the formation of bone mass.[@b29-cia-9-1375] Hyun et al reported a positive correlation between dietary Zn intake, plasma Zn concentration, and BMD.[@b30-cia-9-1375] Similarly, supplementation with Zn and Cu has been found to decrease bone loss in postmenopausal females, and supplementation with Ca paradoxically resulted in reduced absorption of Zn and Cu.[@b31-cia-9-1375],[@b32-cia-9-1375] Cournot and Hercberg underscored the role of trace elements in the prevention and treatment of osteoporosis, focusing on the importance of consuming Mg-rich nutrients, as well as milk and milk products, starting from childhood.[@b33-cia-9-1375] Tranquilli et al reported lower intakes of Ca, P, and Mg in 194 osteoporotic females compared to controls, and found a correlation between these elements and BMD.[@b34-cia-9-1375] They pointed out the importance of appropriate counseling for nutritional supplementation before and after menopause, enriching the diet with these elements, and comprehensive nutritional assessment in the treatment of postmenopausal osteoporosis. Gür et al reported lower Zn and Mg in osteoporotic subjects, and that the addition of trace elements to the diet was efficacious in ameliorating the deficits. They also recommended the use of trace-element assessment in osteoporotic patients with normal Ca or P levels.[@b35-cia-9-1375]

Sojka and Weaver observed a significant increase in bone density and a preventive effect on fractures after 2 years of treatment with Mg(OH)~2~ in a group of postmenopausal females.[@b36-cia-9-1375] In another study, following treatment with Mg for 1 year, an improvement in BMD was detected in comparison with controls.[@b37-cia-9-1375] Steidl and Ditmar administered only Mg lactate to 60 patients with osteoporosis, and observed improvements in pain and spinal movements and no progression in kyphosis or X-ray findings at follow-up assessments at 6 months, 1 year, and 2 years.[@b38-cia-9-1375]

A decrease in trace elements with increasing age has been reported. Zaichick and Zaichick examined the trace elements in human iliac bone, and observed a significant decrease in the Ca, Mg, and P contents with increasing age.[@b39-cia-9-1375] This finding is partially in agreement with our results, which suggested that Ca, Mg, and BMD decreased with age. Therefore, we believe that enriching the diet with trace elements should be considered in elderly populations.

Our study suggested that in the fracture group, the sex effect was important. Zn levels were significantly lower in females than males, while Mn levels were significantly higher. Contrary to previous reports, we detected no other correlation or Ca:Mg-ratio variation according to levels of other trace elements.[@b40-cia-9-1375]--[@b42-cia-9-1375]

The determination of trace elements in living organisms, including bone tissue, is one of the main means by which bioindicators can be used to assess environmental pollution indirectly. Trace elements may not only be bioindicators of environmental exposure to metals in humans but also critical determinants of fracture risk as a result of osteoporosis. Osteoporosis and the occurrence of fractures in an elderly population are complex multifactorial situations, potentially involving genetic, metabolic, and environmental factors. It is perhaps not surprising that no strong association between elemental concentrations and the tendency to fracture was found. Our results support the suggestions of others: that there are systemic differences between the bones of patients with fractures and those of age-matched nonfracture patients, and that other factors determine the risk of fracture. However, we cannot exclude the possibility that trace-element accumulation at specific localized sites, eg, bone-mineralization fronts or within osteoblasts, causes problems, nor can we exclude the possibility that the causes of fracture differ among patients.

Conclusion
==========

We found decreased bone Ca, Mg, and Zn contents in patients with osteoporotic fractures compared to subjects with osteoarthritis. In addition, Ca, Mg, and Zn decreased with age, in parallel with a reduced BMD. These results suggest that these trace elements play an important role in bone breakdown/synthesis. Although the exact role of these trace elements is still unclear, the addition of milk, milk products, or trace element-rich food sources to the diet starting from childhood and supplementation of osteoporotic patients with trace elements in addition to other therapeutic agents seems a reasonable approach. Further studies of the role of trace elements in the etiology and treatment of osteoporosis are warranted.
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###### 

Analysis of CRM-SRM 1486 (bone meal) (μg·g^−1^ dry weight)

  Element   Certified     Measured
  --------- ------------- ------------
  Ca        26.58±0.24    26.46±1.12
  Pb        1.335±0.014   1.32±0.1
  K         412±4         414±5
  Cr        264±7         265±5
  Zn        147±16        147±7

###### 

Recovery rates (%) (n=3)

  μg·mL^−1^   Cu     Zn      Pb
  ----------- ------ ------- ------
  0.5         97±1   98±2    97±2
  1.0         98±2   97±1    98±1
  2.0         99±1   100±2   98±1

###### 

Comparison of the two study groups

  Parameter                                                                                 Fracture group (n=30)   Osteoarthritis group (n =30)   *P* for difference                 
  ----------------------------------------------------------------------------------------- ----------------------- ------------------------------ -------------------- ------------- --------------------------------------------------
  **Biochemical assessments of tissue samples**[a](#tfn1-cia-9-1375){ref-type="table-fn"}                                                                                             
  Magnesium (Mg)                                                                            AM ± SD                 1,908±507                      AM ± SD              2,540±435     \<0.05[b](#tfn2-cia-9-1375){ref-type="table-fn"}
  Median                                                                                    2,183.3                 Median                         2,566.7                            
  Range                                                                                     938--2,818              Range                          1,637--3,357                       
  CV                                                                                        26.57                   CV                             17.14                              
  Calcium (Ca)                                                                              AM ± SD                 10.4±3.5                       AM ± SD              13.9±3.7      \<0.05[c](#tfn3-cia-9-1375){ref-type="table-fn"}
  Median                                                                                    9.7                     Median                         12.8                               
  Range                                                                                     4.8--21.0               Range                          9.3--21.0                          
  CV                                                                                        34.9                    CV                             26.8                               
  Aluminum (Al)                                                                             AM ± SD                 354±189                        AM ± SD              376±223       0.657[c](#tfn3-cia-9-1375){ref-type="table-fn"}
  Median                                                                                    310                     Median                         352.8                              
  Range                                                                                     125--958                Range                          78--1,096                          
  CV                                                                                        53.2                    CV                             168.5                              
  Potassium (K)                                                                             AM ± SD                 124±388                        AM ± SD              119±484       0.215[c](#tfn3-cia-9-1375){ref-type="table-fn"}
  Median                                                                                    0                       Median                         0                                  
  Range                                                                                     0--1,878                Range                          0--2,581                           
  CV                                                                                        313                     CV                             405.3                              
  Vanadium (V)                                                                              AM ± SD                 20±46                          AM ± SD              22±43         0.832[c](#tfn3-cia-9-1375){ref-type="table-fn"}
  Median                                                                                    0                       Median                         0                                  
  Range                                                                                     0--190                  Range                          0--167                             
  CV                                                                                        231.3                   CV                             191.3                              
  Chromium (Cr)                                                                             AM ± SD                 14±38                          AM ± SD              10±32         0.669[c](#tfn3-cia-9-1375){ref-type="table-fn"}
  Median                                                                                    0                       Median                         0                                  
  Range                                                                                     0--152                  Range                          0--134                             
  CV                                                                                        283                     CV                             337                                
  Manganese (Mn)                                                                            AM ± SD                 693±765                        AM ± SD              728±728       0.569[c](#tfn3-cia-9-1375){ref-type="table-fn"}
  Median                                                                                    450                     Median                         545                                
  Range                                                                                     0--2,710                Range                          0--2,803                           
  CV                                                                                        110.4                   CV                             100                                
  Iron (Fe)                                                                                 AM ± SD                 182±241                        AM ± SD              108±107       0.460[c](#tfn3-cia-9-1375){ref-type="table-fn"}
  Median                                                                                    77.1                    Median                         72.2                               
  Range                                                                                     11.4--1,027             Range                          10.3--378                          
  CV                                                                                        110.4                   CV                             98.8                               
  Nickel (Ni)                                                                               AM ± SD                 95±212                         AM ± SD              125±215       0.591[c](#tfn3-cia-9-1375){ref-type="table-fn"}
  Median                                                                                    0                       Median                         0                                  
  Range                                                                                     0--960                  Range                          0--770                             
  CV                                                                                        223.3                   CV                             172.5                              
  Zinc (Zn)                                                                                 AM ± SD                 2,342±1,252                    AM ± SD              3,145±1,604   \<0.05[b](#tfn2-cia-9-1375){ref-type="table-fn"}
  Median                                                                                    2,564                   Median                         3,391                              
  Range                                                                                     0--4,305                Range                          0--6,004                           
  CV                                                                                        53.5                    CV                             51                                 
  Arsenic (As)                                                                              AM ± SD                 10±18                          AM ± SD              20±45         0.932[c](#tfn3-cia-9-1375){ref-type="table-fn"}
  Median                                                                                    3.9                     Median                         1.15                               
  Range                                                                                     0--94                   Range                          0--220                             
  CV                                                                                        181                     CV                             227.2                              
  Selenium (Se)                                                                             AM ± SD                 42±103                         AM ± SD              33±44         0.434[c](#tfn3-cia-9-1375){ref-type="table-fn"}
  Median                                                                                    0.5                     Median                         20.2                               
  Range                                                                                     0--533                  Range                          0--183                             
  CV                                                                                        244.7                   CV                             135.1                              
  Silver (Ag)                                                                               AM ± SD                 637±987                        AM ± SD              517±383       0.322[c](#tfn3-cia-9-1375){ref-type="table-fn"}
  Median                                                                                    234.3                   Median                         488.7                              
  Range                                                                                     0--4,638                Range                          0--1,420                           
  CV                                                                                        154.9                   CV                             74                                 
  Antimony (Sb)                                                                             AM ± SD                 19±36                          AM ± SD              31±51         0.640[c](#tfn3-cia-9-1375){ref-type="table-fn"}
  Median                                                                                    5.3                     Median                         5.7                                
  Range                                                                                     0--188                  Range                          0--165                             
  CV                                                                                        188.7                   CV                             165.7                              
  Barium (Ba)                                                                               AM ± SD                 653±695                        AM ± SD              661±692       0.941[c](#tfn3-cia-9-1375){ref-type="table-fn"}
  Median                                                                                    528.5                   Median                         524                                
  Range                                                                                     26.4--3,831             Range                          64--3,554                          
  CV                                                                                        106.3                   CV                             104.7                              
  Lead (Pb)                                                                                 AM ± SD                 55±92                          AM ± SD              28±57         0.189[c](#tfn3-cia-9-1375){ref-type="table-fn"}
  Median                                                                                    0                       Median                         0                                  
  Range                                                                                     0--314                  Range                          0--207                             
  CV                                                                                        167.9                   CV                             200.7                              

**Notes:**

Tissue levels are expressed as micrograms per gram of dry weight

Student's *t*-test

Mann--Whitney *U* test.

**Abbreviations:** AM, arithmetic mean; SD, standard deviation; CV, coefficient of variation.

###### 

Comparison of the two study groups in terms of density

  Parameter                                                        Fracture group (n=30)   Osteoarthritis group (n =30)   *P* for difference                 
  ---------------------------------------------------------------- ----------------------- ------------------------------ -------------------- ------------- --------------------------------------------------
  **Radiological assessment of tissue samples**                                                                                                              
  Femoral neck density[a](#tfn5-cia-9-1375){ref-type="table-fn"}   AM ± SD                 186.7±139.3                    AM ± SD              226.1±106.4   0.224[b](#tfn6-cia-9-1375){ref-type="table-fn"}
  **DEXA measurements of the contralateral hip**                                                                                                             
  T-score                                                          AM ± SD                 −3.0±1.2                       AM ± SD              −1.1±0.8      \<0.05[c](#tfn7-cia-9-1375){ref-type="table-fn"}
  Z-score                                                          AM ± SD                 −1.13±1.2                      AM ± SD              0.1±0.8       \<0.05[c](#tfn7-cia-9-1375){ref-type="table-fn"}
  BMD (g/cm^2^)                                                    AM ± SD                 0.6±0.1                        AM ± SD              0.8±0.1       \<0.05[b](#tfn6-cia-9-1375){ref-type="table-fn"}

**Notes:**

Based on the Hounsfield scale

Student's *t*-test

Mann--Whitney *U* test.

**Abbreviations:** AM, arithmetic mean; SD, standard deviation; DEXA, dual-energy X-ray absorptiometry; BMD, bone mineral density.
